CPhI News

How the Critical Medicines Act Aims to Optimize European Pharma Competitiveness and Resilience

November 02, 2025

Maggie Saykali reviews the key points of her CPHI Frankfurt presentation on the potential game-changing opportunities of the Critical Medicines Act.

Clearing Hurdles in Sustainability, AI, and CDMO Partnerships

October 31, 2025

J.D. Mowery, Bora, says global sustainability standards are good, AI implementation demands data cleansing, and outsourcing must mature.

Standardizing Operations to Meet Global Sustainability and Resilience Goals

October 31, 2025

J.D. Mowery discusses boosting pharma supply resilience through localized manufacturing, AI innovation, and critical regulatory standardization.

US and European Pharma Manufacturing Face Diverging Paths to Resilience

October 30, 2025

Maggie Saykali, Cefic, explains that Western pharma vulnerability stems from market loss to Asia, caused largely by short-sighted offshoring due to environmental costs.

Excipient Innovation and the Regulatory Tug-of-War: Navigating Threats to Availability and Safety

October 30, 2025

Turning Real-World Data into Actionable Drug Development Insights With AI

October 30, 2025

Gustavo Ferrer, MD, explains how AI accelerates drug development and manufacturing, streamlining clinical data into actionable pharma insights.

The Bio/pharma Industry Navigates AI’s Impact on Workforce and Hiring

October 30, 2025

A panel at CPHI Frankfurt discussed how AI is transforming pharma talent, necessitating rapid upskilling, bias mitigation, and regulatory changes.

Excipient Innovation, Safer Solvents, and Supply Chain Resilience

October 29, 2025

Nigel Langley of gChem stresses excipient innovation, safer solvents, and supply chain resilience for pharma’s future in part 2 of a 2-part interview related to his presentation at CPHI Europe 2025.

AI and Human Collaboration Essential for Bio/pharma Innovation

October 29, 2025

Eva-Maria Hempe, NVIDIA, says AI collaboration optimizes life science research via routine automation, freeing human experts for complex strategy, ethics, and exploring scarce data.

Best Practices for AI Adoption in Pharmaceutical Research

October 29, 2025

Eva-Maria Hempe, NVIDIA, says AI platforms must integrate R&D data, overcoming silos, with adoption demanding a centralized strategy and change management.